Kenneth W. Harlow has extensive experience in biotechnology, life sciences, and diagnostics. He is currently the CEO and board member at Aligned Bio, a company focused on developing and commercializing innovative nanoscale technology. Kenneth has previously held leadership roles at several companies, including ilochip Bioscience A/S, EXIQON A/S, ZEALAND PHARMA A/S, and DuPont Nutrition Biosciences ApS. He holds a PhD in biochemistry from the University of Illinois and has strong entrepreneurial and business development skills, complemented by deep technical expertise in protein chemistry, bioanalysis and bioprocessing, molecular biology, and in vitro diagnostics/assay development. Kenneth also has significant experience in generating and managing intellectual property portfolios.

LinkedIn

Soren Echwald is a seasoned professional with extensive experience in the life sciences and biotechnology sectors. Soren has a strong academic background, holding a PhD in Molecular Biology from the University of Copenhagen. Throughout his career, he has held various leadership positions, including roles at Exiqon and Qiagen, where he contributed significantly to the development of innovative molecular diagnostic solutions. Soren's expertise spans molecular biology, genomics, and biotechnology, making him a valuable asset to any organization focused on advancing scientific research and technology.

LinkedIn

Magnus Jönsson has extensive experience in finance and accounting. Magnus was a Partner and Authorized Public Accountant at PwC Sweden, where he worked for over a decade. He also served as the Head of Accounting at Orkla Sverige and as an Authorized Public Accountant at PwC Sweden. Magnus holds a degree in Business Administration from Lund University and has also studied at the University of Ottawa.

LinkedIn

Pete holds a PhD in Molecular Genetics from the University of Cambridge and has over 20 years of experience in global core clinical laboratory, Point-of-Care immunoassay, and molecular diagnostics markets, Pete has focused on commercialising R&D and third-party innovative technologies in a number of Life Science and IVD businesses in the UK and US, including Alere, Oxford Gene Technology, Arrow Therapeutics, and Oxonica Healthcare plc. This has included applications for novel nanoparticle biolabels, DNA microarray analysis, genomic technologies for drug development, and new platforms for rapid, in-field diagnostics with digital connectivity. As the former Chief Technology Officer of BBI Solutions, a leading independent provider of diagnostic reagents and services, Pete was responsible for M&A, Commercial Strategic Partnerships and technology Licensing/R&D, building out their product and innovative technology portfolios.More recently Pete has worked with the US Life Science Tools and Diagnostics Growth Capital Investor, BroadOak Capital Partners, identifying European investment and M&A opportunities in addition to working with several UK diagnostic start-ups to mentor their commercial development.

LinkedIn

Experienced Engineer and Manager with a demonstrated history of working in the nanotechnology industry. Skilled in Project Management, Materials Science, Nanotechnology, and Physics. Strong engineering professional graduated with a Master in Physics from Linköping Institute of Technology.

LinkedIn

Karin Blume is a highly experienced professional in the field of immunology and virology. She holds a Doctor of Philosophy (PhD) in Immunology from the University of Tübingen, where she also completed her studies in Biology, Immunology, and Virology.

LinkedIn